Bank of America’s Kestra Medical Technologies KMTS Stock Holding History
Bought
Maintained
Sold
Other funds holding KMTS
BCI
AP
YF
EAM
Bank of America's KMTS Position: Q1 2026 in Review
Bank of America reduced its Kestra Medical Technologies (KMTS) stake by 8.3% in Q1 2026, selling an estimated $110K and leaving 51,479 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #4514.
Bank of America first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.49M in Q4 2025. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.
- Bank of America held 51,479 shares of Kestra Medical Technologies worth $1.03M as of Q1 2026.
- Bank of America sold 4,686 Kestra Medical Technologies shares in Q1 2026, an estimated $110K.
- Kestra Medical Technologies made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4514 holding.
- Bank of America first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
- Bank of America's Kestra Medical Technologies position peaked at $1.49M in Q4 2025.
- 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.